PLoS Med: 妊娠首次出现高血糖后进展为2型糖尿病的相关危险因素的研究

2019-10-19 不详 MedSci原创

全球数据表明,在妊娠中首次发现高血糖病史的女性(HFDP)患上2型糖尿病(T2DM)的风险是那些没有并发高血糖症的女性的2倍,本项研究的目的是确定在南非开普敦发生HFDP后5至6年发展为T2DM的妇女比例和相关危险因素。

背景
全球数据表明,在妊娠中首次发现高血糖病史的女性(HFDP)患上2型糖尿病(T2DM)的风险是那些没有并发高血糖症的女性的2倍,本项研究的目的是确定在南非开普敦发生HFDP后5至6年发展为T2DM的妇女比例和相关危险因素。

方法和发现
研究人员对所有患有HFDP的妇女在5至6年后进行了横断面研究。每个参与者进行75 g口服葡萄糖耐量测试。共有220名参与者得到了随访,他们的平均年龄为37.2岁(SD 6.0)。48%(95%CI 41.2–54.4)进展为T2DM,5.5%(95%CI 3.1–9.4)空腹血糖偏高,而10.5%(95%CI 7.0–15.3)葡萄糖耐量测试阳性。在发展为T2DM的参与者中,有47%不了解自己的糖尿病状态,发展为T2DM的风险相关的因素是;腰围(比值[OR] 1.1,95%CI 1.0–1.1,p = 0.007),髋围(OR 0.9,95%CI 0.8-1.0,p = 0.001)和BMI(OR 1.1,95%CI 1.0-1.3,p = 0.001),在基线时:胰岛素(OR 25.8, 95%CI 3.9–171.4,p = 0.001)和HFDP期间口服降糖治疗(OR 4.1,95%CI 1.3–12.9,p = 0.018),禁食(OR 2.7,95%CI 1.5–4.8,p = 0.001),以及口服葡萄糖耐量试验在HFDP诊断时2小时的血糖浓度(OR 4.3,95%CI 2.4–7.7,p < 0.001)。

结论
本项研究表明预防HFDP的干预措施也可能有助于降低T2DM的发生风险。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1948387, encodeId=bb40194838ef0, content=<a href='/topic/show?id=a646e252819' target=_blank style='color:#2F92EE;'>#相关危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72528, encryptionId=a646e252819, topicName=相关危险因素)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uiafWKNzZJdibyrrAR5YyVBUCbj0fhAekic1Tou5YEI9IBoJ1QrGpZylYAkiafDNofZkNHJCPTpY1HK14LvuFzD5xQ/132, createdBy=706e2500208, createdName=ms9203727104890838, createdTime=Thu Feb 27 08:05:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1261188, encodeId=4c3f12611888b, content=<a href='/topic/show?id=30c6102e2607' target=_blank style='color:#2F92EE;'>#高血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102726, encryptionId=30c6102e2607, topicName=高血糖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Oct 21 13:05:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610040, encodeId=f1c4161004097, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Oct 21 13:05:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042783, encodeId=46c81042e83ea, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Oct 20 01:05:00 CST 2019, time=2019-10-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1948387, encodeId=bb40194838ef0, content=<a href='/topic/show?id=a646e252819' target=_blank style='color:#2F92EE;'>#相关危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72528, encryptionId=a646e252819, topicName=相关危险因素)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uiafWKNzZJdibyrrAR5YyVBUCbj0fhAekic1Tou5YEI9IBoJ1QrGpZylYAkiafDNofZkNHJCPTpY1HK14LvuFzD5xQ/132, createdBy=706e2500208, createdName=ms9203727104890838, createdTime=Thu Feb 27 08:05:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1261188, encodeId=4c3f12611888b, content=<a href='/topic/show?id=30c6102e2607' target=_blank style='color:#2F92EE;'>#高血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102726, encryptionId=30c6102e2607, topicName=高血糖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Oct 21 13:05:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610040, encodeId=f1c4161004097, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Oct 21 13:05:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042783, encodeId=46c81042e83ea, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Oct 20 01:05:00 CST 2019, time=2019-10-20, status=1, ipAttribution=)]
    2019-10-21 hbwxf
  3. [GetPortalCommentsPageByObjectIdResponse(id=1948387, encodeId=bb40194838ef0, content=<a href='/topic/show?id=a646e252819' target=_blank style='color:#2F92EE;'>#相关危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72528, encryptionId=a646e252819, topicName=相关危险因素)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uiafWKNzZJdibyrrAR5YyVBUCbj0fhAekic1Tou5YEI9IBoJ1QrGpZylYAkiafDNofZkNHJCPTpY1HK14LvuFzD5xQ/132, createdBy=706e2500208, createdName=ms9203727104890838, createdTime=Thu Feb 27 08:05:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1261188, encodeId=4c3f12611888b, content=<a href='/topic/show?id=30c6102e2607' target=_blank style='color:#2F92EE;'>#高血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102726, encryptionId=30c6102e2607, topicName=高血糖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Oct 21 13:05:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610040, encodeId=f1c4161004097, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Oct 21 13:05:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042783, encodeId=46c81042e83ea, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Oct 20 01:05:00 CST 2019, time=2019-10-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1948387, encodeId=bb40194838ef0, content=<a href='/topic/show?id=a646e252819' target=_blank style='color:#2F92EE;'>#相关危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72528, encryptionId=a646e252819, topicName=相关危险因素)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uiafWKNzZJdibyrrAR5YyVBUCbj0fhAekic1Tou5YEI9IBoJ1QrGpZylYAkiafDNofZkNHJCPTpY1HK14LvuFzD5xQ/132, createdBy=706e2500208, createdName=ms9203727104890838, createdTime=Thu Feb 27 08:05:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1261188, encodeId=4c3f12611888b, content=<a href='/topic/show?id=30c6102e2607' target=_blank style='color:#2F92EE;'>#高血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102726, encryptionId=30c6102e2607, topicName=高血糖)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Oct 21 13:05:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610040, encodeId=f1c4161004097, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Oct 21 13:05:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042783, encodeId=46c81042e83ea, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sun Oct 20 01:05:00 CST 2019, time=2019-10-20, status=1, ipAttribution=)]
    2019-10-20 misszhang

    谢谢MedSci提供最新的资讯

    0

相关资讯

BMJ:Sotagliflozin治疗1型糖尿病的安全性及有效性分析

双重葡萄糖协同转运蛋白(SGLT)1/2参与体内血糖的调控,控制这条路径可以减少糖尿病的发生,因此,本项研究旨在评价双重葡萄糖协同转运蛋白(SGLT)1/2抑制剂sotagliflozin在治疗1型糖尿病中的疗效和安全性。

European J Endocrinology:在患有2型糖尿病的成年患者中骨形成的能力减弱

人体的骨转换受到食物摄入,肠促胰岛素激素,交感神经系统和骨细胞功能影响的昼夜变化影响。本项研究的目的是比较糖尿病患者和对照组骨转换的昼夜变化。

BMJ: 膳食脂肪的质量和遗传风险对2型糖尿病发病率的影响

本项研究旨在探讨2型糖尿病的遗传负荷是否改变了膳食脂肪质量与2型糖尿病发病率的关系。

Clinical Nutrition:健康的饮食模式及其相应的肠道微生物群特征与2型糖尿病风险较低有关

糖尿病前期和老年人都是发生二型糖尿病(T2D)的高危因素,而肥胖是引发该疾病的最重要因素之一。营养干预是预防T2D的最有效工具,因为它可以促进/抑制肠道微生物群的增长。然而,到目前为止,没有具体的饮食建议来延缓老年人群中T2D的发展。因此,本项研究的目的是了解饮食模式对肥胖和非肥胖老年前驱糖尿病受试者的肠道微生物群特征的影响以及对T2D发生风险的影响。

BMJ:饮食在2型糖尿病发病中的作用

饮食在糖尿病的发病中起到了关键作用,本项研究旨在探究饮食因素与2型糖尿病发病之间的关系,并评估这些关联的强度和有效性。

BMJ: 前列腺增生患者接受类固醇5α-还原酶抑制剂治疗后患2型糖尿病概率增加

类固醇5α-还原酶抑制剂是治疗良性前列腺增生的一线药物,但是其不良反应还没有明确报道,本项研究旨在探讨接受类固醇5α-还原酶抑制剂(度他雄胺或非那雄胺)长期治疗良性前列腺增生的男性新发2型糖尿病的发病率情况。